Pages that link to "Q44378853"
Jump to navigation
Jump to search
The following pages link to Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension (Q44378853):
Displaying 12 items.
- HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT (Q28294446) (← links)
- Menopause care for obese and diabetic women. (Q34608171) (← links)
- A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria (Q35068814) (← links)
- Hormone replacement therapy update: who should we be prescribing this to now? (Q35587247) (← links)
- Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article (Q36359547) (← links)
- C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity (Q37097920) (← links)
- Sexual dimorphism in the aging kidney: differences in the nitric oxide system (Q37504674) (← links)
- Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes (Q43461389) (← links)
- Metabolic and hormonal parameters in post-menopausal women 10 years after transdermal oestradiol treatment, alone or combined to micronized oral progesterone. (Q44133863) (← links)
- Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis (Q47551752) (← links)
- Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study. (Q51937664) (← links)
- Estrogen Deficiency Promotes Hepatic Steatosis via a Glucocorticoid Receptor-Dependent Mechanism in Mice. (Q52689242) (← links)